Heartworm disease (Dirofilaria immitis) is a serious and potentially fatal condition in dogs, particularly prevalent in tropical and subtropical climates but present across wide geographic ranges globally. The standard three-dose melarsomine (Immiticide/Diroban) adulticidal treatment protocol — used in conjunction with doxycycline and macrocyclic lactones as recommended by the American Heartworm Society — achieves clearance of heartworm infection in 98% of dogs. However, the treatment process itself carries significant risks. A retrospective study at Louisiana State University found that 52% of dogs experienced complications during or after heartworm treatment, ranging from injection site reactions and GI signs to the most serious risk: pulmonary thromboembolism from dying adult worms.
Why heartworm treatment follow-up centres on one non-negotiable instruction
Activity restriction is the most critical and most frequently violated component of heartworm treatment. As adult worms die following melarsomine administration, fragments and whole worms are swept into the pulmonary circulation. Physical activity during this period dramatically increases blood flow to the lungs and significantly raises the risk of pulmonary thromboembolism — a potentially fatal complication characterised by coughing, haemoptysis, respiratory distress, and collapse. The American Heartworm Society is explicit: dogs should have their activity restricted before, during, and for two months following melarsomine treatment. Activity level is described as one of the most significant predictors of treatment-related complications.
This instruction is harder to enforce than it appears. Dogs that respond well to treatment feel significantly better as worms die and microfilarial burden decreases. An owner managing a dog that seems completely normal — wanting to run, play, and behave as it did before the disease — faces a genuine challenge in maintaining strict rest for eight weeks. A follow-up system that regularly reminds and reinforces the activity restriction, and asks direct questions about compliance, is the only consistent mechanism the clinic has for catching non-compliance before it causes a thrombotic event.
The recommended post-treatment monitoring includes a microfilarial test at one month and a heartworm antigen test plus microfilarial test at nine months. Both require proactive owner engagement — and both are frequently not completed without a reminder.
The heartworm treatment follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 24–72 hours post-injection | Injection site reaction (mild swelling and tenderness expected, significant swelling or pain is not), GI signs from doxycycline, activity restriction enforced | Severe injection site reaction requiring intervention; significant respiratory distress — potential early thromboembolism; owner has allowed normal activity |
| 1–2 weeks | Activity restriction continuing, clinical signs stable or improving, injection site healed, respiratory symptoms absent | Coughing, haemoptysis, shortness of breath, weakness or pale gums — signs of pulmonary thromboembolism; owner has allowed exercise |
| 1 month post-treatment | Microfilarial test, clinical signs assessed, activity still restricted (minimum 2 months from last injection) | Positive microfilarial test — macrocyclic lactone dose or protocol review needed |
| 9 months post-treatment | Heartworm antigen test and microfilarial test to confirm treatment success | Positive antigen test — treatment has not fully cleared infection; re-treatment decision needed |
| Ongoing | Year-round heartworm prevention maintained, annual testing | Positive test on annual screening — new infection |
What to ask owners during heartworm treatment follow-up
- Is [dog name] on strict rest — no running, jumping, stairs, or off-lead time?
- Has he had any coughing, difficulty breathing, or shortness of breath?
- Is he lethargic or showing any signs of weakness?
- Has the injection site healed — no excessive swelling, pain, or discharge?
- Has he had any vomiting, diarrhoea, or reduced appetite from the doxycycline?
- Have there been any situations where strict rest has been difficult — visitors, other dogs, outdoor access?
- What arrangements do you have in place to maintain the activity restriction — is he crated or in a restricted space when unsupervised?
- Do you know exactly what signs of pulmonary thromboembolism look like — and what to do if you see them?
- Have you booked your one-month microfilarial test appointment?
- Is he on his monthly heartworm prevention as prescribed — macrocyclic lactones as directed?
Common heartworm follow-up mistakes clinics make
Not being specific enough about what “restricted activity” means. “Keep him calm” and “restricted activity” produce very different owner behaviours depending on interpretation. Owners need to know specifically: leash walks for toilet only, no stairs, no running, no play, crated or in a small room when unsupervised, for two months from the last melarsomine injection. A follow-up call that asks “has he had any off-lead time or periods of running?” — not “has he been resting?” — catches the gap between owner perception and clinical standard.
Not briefing owners on thromboembolism warning signs. Signs of pulmonary thromboembolism — coughing, blood in sputum, breathing difficulty, sudden weakness or collapse — may appear days to weeks after melarsomine administration. Owners who have not been explicitly briefed may misattribute these to unrelated causes or delay seeking emergency care. A follow-up call that asks specifically about respiratory symptoms and reinforces the emergency protocol is clinically essential.
Missing the 9-month test. The one-month microfilarial test has reasonable owner awareness — it comes shortly after treatment. The nine-month antigen test — which is the definitive confirmation of treatment success — is much more frequently missed. A proactive reminder call at the eight-month mark keeps this critical test on the owner’s radar.
How to automate heartworm follow-up without adding to your team’s workload
Nidana Loop schedules weekly activity restriction reminders and respiratory symptom checks during the 8-week post-treatment period, along with a one-month microfilarial test reminder and a nine-month antigen test reminder. For dogs showing any respiratory symptoms reported on a follow-up call, Loop immediately flags the case as urgent. The consistent touchpoints during the high-risk activity restriction period provide the reinforcement that makes compliance achievable.
See how Loop handles heartworm follow-up calls → Book a 20-minute demo
Related: Congestive heart failure follow-up · Chemotherapy follow-up · Kennel cough aftercare